Cargando…

Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator

BACKGROUND: Cardiac resynchronisation therapy (CRT) is a well-established form of treatment for patients with heart failure and cardiac dyssynchrony. There are two different types of CRT devices: the biventricular pacemaker (CRT-P) and the biventricular defibrillator (CRT-D). The latter is more comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hadwiger, Moritz, Frielitz, Fabian-Simon, Eisemann, Nora, Elsner, Christian, Dagres, Nikolaos, Hindricks, Gerhard, Katalinic, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790776/ https://www.ncbi.nlm.nih.gov/pubmed/32215877 http://dx.doi.org/10.1007/s40258-020-00571-y

Ejemplares similares

A long-term cost-effectiveness analysis of cardiac resynchronisation therapy with or without defibrillator based on health claims data
por: Hadwiger, Moritz, et al.
Publicado: (2022)

Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project
por: Hadwiger, Moritz, et al.
Publicado: (2022)

Device runtime and costs of cardiac resynchronization therapy pacemakers – a health claims data analysis
por: Hadwiger, Moritz, et al.
Publicado: (2022)

Clinical utility of cardiovascular magnetic resonance imaging in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptoms
por: Lindemann, Frank, et al.
Publicado: (2020)

Ethical issues in two parallel trials of personalised criteria for implantation of implantable cardioverter defibrillators for primary prevention: the PROFID project—a position paper
por: Willems, Dick, et al.
Publicado: (2021)

The PROFID project
por: Dagres, Nikolaos, et al.
Publicado: (2020)

Diagnosis of atrial fibrillation in heart failure patients with implantable cardioverter defibrillator or cardiac resynchronisation therapy
por: Dominik, Barbara, et al.
Publicado: (2021)

Age of cardiac resynchronisation therapy; cardiac resynchronisation therapy in elderly
por: Cerit, Levent
Publicado: (2016)

Sleep Disorders and Atrial Fibrillation: Current Situation and Future Directions
por: Sepehri Shamloo, Alireza, et al.
Publicado: (2018)

Exercise and Atrial Fibrillation: Some Good News and Some Bad News
por: Sepehri Shamloo, Alireza, et al.
Publicado: (2018)

Aortic perforation due to cardiac resynchronisation therapy defibrillator lead placement: Case report and medicolegal considerations
por: Grande, Antonino M., et al.
Publicado: (2015)

Trends in implantable cardioverter defibrillator and cardiac resynchronisation therapy lead parameters for patients with arrhythmogenic and dilated cardiomyopathies
por: Lane, Jem D., et al.
Publicado: (2018)

Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation
por: Ueberham, Laura, et al.
Publicado: (2017)

Clinical utility of speckle-tracking echocardiography in cardiac resynchronisation therapy
por: Khan, Sitara G, et al.
Publicado: (2016)

Imputation of missing values of tumour stage in population-based cancer registration
por: Eisemann, Nora, et al.
Publicado: (2011)

ENDURALIFE-Powered Cardiac Resynchronisation Therapy Defibrillator Devices for Treating Heart Failure: A NICE Medical Technology Guidance
por: Evans, James Michael, et al.
Publicado: (2017)

Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial
por: Hindricks, Gerhard, et al.
Publicado: (2014)

Is Cardiac Resynchronisation Therapy Proarrhythmic?
por: Leyva, Francisco, et al.
Publicado: (2008)

Gender in cardiac resynchronisation therapy
por: Enina, Tatiana N., et al.
Publicado: (2018)

Improving Cardiac Resynchronisation Therapy
por: Thomas, George, et al.
Publicado: (2019)

Cost-effectiveness of cardiac resynchronisation therapy for patients with moderate-to-severe heart failure: a lifetime Markov model
por: Neyt, Mattias, et al.
Publicado: (2011)

Study results from journals with a higher impact factor are closer to “truth”: a meta-epidemiological study
por: Heidenreich, Andreas, et al.
Publicado: (2023)

Current aspects of cardiac resynchronisation therapy
por: Meine, M., et al.
Publicado: (2015)

Cardiac resynchronisation therapy in optima forma
por: Timmer, S. A. J., et al.
Publicado: (2022)

Cardiac resynchronisation therapy in optima forma
por: Timmer, S. A. J., et al.
Publicado: (2022)

Conduction System Pacing for Cardiac Resynchronisation
por: Sharma, Parikshit S, et al.
Publicado: (2021)

Cardiac Resynchronisation with Conduction System Pacing
por: Ezzeddine, Fatima M, et al.
Publicado: (2023)

Managing arrhythmia in cardiac resynchronisation therapy
por: de Vere, Felicity, et al.
Publicado: (2023)

Progress in Cardiac Resynchronisation Therapy and Optimisation
por: Akhtar, Zaki, et al.
Publicado: (2023)

Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trial
por: Geller, Johann Christoph, et al.
Publicado: (2019)

Cardiac Resynchronisation Therapy and Cellular Bioenergetics: Effects Beyond Chamber Mechanics
por: Antoniou, Christos-Konstantinos, et al.
Publicado: (2019)

Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillation
por: Schumacher, Katja, et al.
Publicado: (2018)

Initial rivaroxaban dosing in patients with atrial fibrillation
por: Ablefoni, Kaja, et al.
Publicado: (2019)

Rate of acquired pulmonary vein stenosis after ablation of atrial fibrillation referred to electroanatomical mapping systems: Does it matter?
por: Schoene, Katharina, et al.
Publicado: (2019)

Patients’ attitude towards a sham-controlled trial on pulmonary vein isolation in atrial fibrillation
por: Uhe, Tobias, et al.
Publicado: (2021)

Echocardiography and cardiac resynchronisation therapy, friends or foes?
por: van Everdingen, W.M., et al.
Publicado: (2015)

Optimisation of cardiac resynchronisation therapy during exercise
por: Ghani, A., et al.
Publicado: (2013)

Resynchronisation as an Element of Improving Cattle Reproduction Efficiency
por: Jaśkowski, Jędrzej M., et al.
Publicado: (2019)

Effect of cardiac resynchronisation therapy in dilated cardiomyopathy
por: Bouwmeester, S., et al.
Publicado: (2021)

Automatic daily remote monitoring in heart failure patients implanted with a cardiac resynchronisation therapy-defibrillator: a single-centre observational pilot study
por: Ezer, Peter, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gn4gt0bfkohobev8599i5qu7l9